In a similar way to sharing companies like AirBnB help make use of vacant or partially vacant accommodation, we are helping to make use of under-utilised computers. Those computers are everywhere, in the cloud, in bedrooms, offices, all over the world. We provide access to those computers in a way that is simple enough for anyone to use. Effectively, we sell access to computational power, but we own no computers.

Read More→

Langzou Technologies

Langzou Technologies develops state of the art 3D computer vision and computer graphics technologies and builds smart city platforms on top of them. It serves governments, campus owners and buildings with digital twin solutions with a series of IOT applications. With these solutions, space management from city scale to building scale becomes much more efficient. Langzou’s vision is to build a more reliable space management system that lets operators run with confidence.

Read More→

Acumen Research Labs

Acumen has developed AcuSeptTM — a novel, blood-based Sepsis Host Response test using sepsis-specific mRNA biomarkers — that can assist the doctos to detect sepsis in patients in 4-5 hrs, earlier and more accurately than current methods.

Intended Use:
AcuSeptTM generates diagnostic scores which fall in the range of either above or below a validated threshold level that determines the risk of sepsis. AcuSeptTM results are to be used in conjunction with clinical assessments and other laboratory findings as an aid to identify patients with low or high risk of infection and sepsis.

Clinical Utility:
・To differentiate patients with and without infection
・To differentiate patients with and without sepsis
・Can identify sepsis early

Read More→

Wish-Alize CO. Ltd.

Legislation of medical Device traceability will start in the United States in 2020 first and EU and other countries will follow.
Medical professionals pay attention to surgical instrument traceability issue in various countries including Japan as it contributes to patient safety in the end.

Looking at objective of tracability, some Japanese medical professionals misunderstand it as “Identification of indivisual surgical instrument” through barcode but it should include “evaluation of surgical instrument condition (cleaness, functionality and deterioration)” to avoid surgical site infection to the patients. Our goal is realizing quantitaive evaluation system of surgical instrument condition to contribute patient safety.

Read More→

PT. Inovasi Bioproduk Indonesia

The major use of seaweed has been predominantly for human consumption. Call to increase consumption has long been made for seaweed gets highly regard as sustainable food potential. Besides its use in functional foods, seaweed also finds its way in processed, powdered forms used as hydrocolloids, texturing agents, and/ or stabilizers, for food, pharmacy, and cosmetic industries. The Global demand for particular use of seaweed in the form of empty capsule for instance, is expected to further increase in an annual growth rate averaging 7.3% per annum since 2016 and is projected to continue until 2026.
 Seaweed as the main input to Inobi’s production system has been becoming an important commodity to support the economy of the coastal area. Indonesia, commonly known as a country with the second longest shore line in the World, has huge potential. Combination of climatological aspect and ecology provides a perfect environment for seaweed cultivation. These facts make seaweed become one of Indonesia’s leading marine commodity in the Global market to date. Currently, Indonesia is the second best world’s seaweed producing country after Chile. Indonesia seaweed production in 2010 reached 3.082 million tons, exceeding the target set by the Ministry of Maritime Affairs and Fisheries (KKP) of 2.574 million tons. Further increase in production of 3.504 million tons in 2011, 5.1 million tons in 2012, 7.5 million tons in 2013. Indonesian seaweeds are commonly produced and exported in the form of dried seaweed and/or semi-finished product for example carrageenan, alginate and gelatine.
 Hard Capsules are solid preparations consisting of drugs in hard or soft shells that can dissolve. The shell is generally made from gelatin. Gelatin is a hydrolysis product from collagen that comes from the skin, tissue and bones of animals that are commonly used, namely from the bones of cattle or buffalo and pig bones. Hard capsule product from seaweed is an alternative gelatin capsule, important for Muslims, Jews, Hindus, Vegetarians and Others on dietary reason. The recent trends of increasing demand for plant based capsule husks finds its explanation not only in the aforementioned communities but more importantly in the changing lifestyle due to the improved awareness and the shift in the value of healthy life, whereby people exempt themselves from animal based- and derivate products and instead opt more for seaweed as healthier option.

Read More→


Minet is a technology company in marketing field. We build a platform connecting brands who want to advertise through influencers on social networks. Our platform use Big Data and AI into a problems of optimizing campaign effectiveness by analyzing demographics and followers of influencers on social networks as well as analyzing the real or fake interaction of their accounts. From there, the system will automatically propose list influencers which is the most relevant to the brands. Beside, Big Data and AI automatically search and filter list influencer which match with Minet’s influencer networks.

Read More→

uHoo Pte Ltd

Our goal is to improve the health and wellbeing of every person by creating products and services that creates the importance of knowing the kind of environment people live in, how it affects their lives on a daily basis, and guide the actions needed to improve their environment, health and wellbeing.

Read More→

Warden Machinery/Machine Vision LLC

Warden Machinery – Russia-based startup with an office in Lithuania specializing in serial R&D and integration of machine vision-based solutions for the following industrial applications: quality control, sorting and segmentation, manual service labor control and augmentation, compliance control, safety and security monitoring, robotics, and automation. In brief, we optimize manufacturing and service procedures wherever possible, reinforce compliance control and support for those who are essential, enabling our clients to do more with less — more yield with less energy, fewer materials, and fewer labor hours.

 Our three major domains of operations comprise human behavioral analytics, visual defects detection in complex engineering systems and conveyor manufacturing, and real-time vision systems for industrial robots based on AI. Our neural networks can work in both GPU server and edge computation architectures.

 Our team consists of 16 PhD/PhD Student-level researchers in Computer Science and Robotics.

 We have received international recognition within startup contests conducted by large corporations including, for instance, Hager Group and Schneider Electric. Being focused on back-end technologies, we scale up by outsourcing sales and marketing to our strategic industrial partners, such as SAP CIS&SE, Schneider Electric, and PricewaterhouseCoopers.
SAP and BIG4 consultants trust us. Will you?

Read More→


Motorica is a company with offices in Russia (HQ), China and India focusing on research and development in medicine and robotics. Since its establishment, the company has been developing artificial hand systems and rehabilitation with assistive technologies. Half of the team are R&D staff and medical specialists.
 Motorica challenges the outdated ideas about prosthetic care. The team taught prostheses to communicate with the user, go online, perform voice commands, pay for purchases. In 2018, Motorica launched the development of a rehabilitation platform based on virtual reality and a platform for collecting telemetry via gsm-module in prosthetic devices. Nowadays, people with disabilities become the primary users of the cyber technology market and turn weaknesses into strengths.

Read More→


UNIM is a Russian medical IT company who develops solutions for oncology diagnostics. Company has created Digital Pathology© system – end-to-end solution for digitalization of the pathomorphological laboratory. UNIM has opened 100% digital pathology laboratory in Technopark Skolkovo in January 2018, where more than 3,500 patients get their diagnosis every month. More than 1000 highly specialized consultants use the Digital Pathology© system to meet remotely via the Internet same as they would at a multi-head microscope, and perform real-time case analysis. Digital Pathology© provides collective work on each case, attraction of narrow specialists from all over the world, transparency of the diagnostic process, opportunities for interdisciplinary communication and integration of neural networks in diagnostic process. The company combines all the competencies necessary to develop a competitive convenient product and its successful commercialization: management, developers, doctors, sales.

Read More→